Advertisement
CRL vs IQV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and IQV is a StrongBuy.
CRL sees its Stochastic Oscillator climbs out of oversold territory
On November 09, 2026, the Stochastic Oscillator for CRL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In 41 of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +12.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 200 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 147 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for CRL moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRL as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for CRL turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 36 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 1 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.674) is normal, around the industry mean (67.298). P/E Ratio (-70.170) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
IQV in upward trend: price rose above 50-day moving average on November 06, 2026
IQV moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 21 of 28 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on IQV as a result. In 49 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for IQV just turned positive on November 10, 2026. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in 26 of 41 cases over the following month. The odds of a continued upward trend are 63%.
Following a +5.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
IQV broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.251) is normal, around the industry mean (67.298). P/E Ratio (33.477) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
CRL | IQV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 83 | |
SMR RATING 1..100 | 93 | 43 | |
PRICE GROWTH RATING 1..100 | 1 | 9 | |
P/E GROWTH RATING 1..100 | 91 | 27 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRL's Valuation (13) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for IQV (77) in the Servicestothe Health Industry industry. This means that CRL’s stock grew somewhat faster than IQV’s over the last 12 months.
IQV's Profit vs Risk Rating (83) in the Servicestothe Health Industry industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that IQV’s stock grew similarly to CRL’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for CRL (93) in the Miscellaneous Commercial Services industry. This means that IQV’s stock grew somewhat faster than CRL’s over the last 12 months.
CRL's Price Growth Rating (1) in the Miscellaneous Commercial Services industry is in the same range as IQV (9) in the Servicestothe Health Industry industry. This means that CRL’s stock grew similarly to IQV’s over the last 12 months.
IQV's P/E Growth Rating (27) in the Servicestothe Health Industry industry is somewhat better than the same rating for CRL (91) in the Miscellaneous Commercial Services industry. This means that IQV’s stock grew somewhat faster than CRL’s over the last 12 months.
| CRL | IQV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | N/A |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 72% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 67% |
| Advances ODDS (%) | 3 days ago 70% | 3 days ago 62% |
| Declines ODDS (%) | 7 days ago 69% | 10 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 58% |
| Aroon ODDS (%) | 2 days ago 64% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRL’s FA Score shows that 2 FA rating(s) are green while IQV’s FA Score has 2 green FA rating(s).
- CRL’s FA Score: 2 green, 3 red.
- IQV’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRL’s TA Score shows that 3 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).
- CRL’s TA Score: 3 bullish, 5 bearish.
- IQV’s TA Score: 4 bullish, 3 bearish.
Price Growth
CRL (@Medical Specialties) experienced а -1.73% price change this week, while IQV (@Medical Specialties) price change was +4.78% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.
Reported Earning Dates
CRL is expected to report earnings on Feb 24, 2027.
IQV is expected to report earnings on Feb 11, 2027.
Industries' Descriptions
@Medical Specialties (-4.92% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
CRL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To CRL | 1D Price Change % | ||
|---|---|---|---|---|
| CRL | 100% | -2.13% | ||
| RGEN - CRL | 56% Loosely correlated | -2.77% | ||
| AZTA - CRL | 56% Loosely correlated | -1.15% | ||
| MEDP - CRL | 56% Loosely correlated | -1.25% | ||
| BRKR - CRL | 53% Loosely correlated | -6.46% | ||
| SHC - CRL | 52% Loosely correlated | -1.03% | ||
More | ||||
IQV and
Correlation & Price change
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | -1.32% | ||
| CRL - IQV | 71% Closely correlated | -2.13% | ||
| TMO - IQV | 67% Closely correlated | -0.48% | ||
| RVTY - IQV | 59% Loosely correlated | -1.01% | ||
| A - IQV | 58% Loosely correlated | -1.27% | ||
| ICLR - IQV | 54% Loosely correlated | -1.43% | ||
More | ||||